Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?

Judy A Tjoe; Philippe Gascard; Jianxin Zhao; Gary F Neitzel; Maharaj Singh; Brittany Last; James Marx; Thea Tlsty; Sanjay Kansra

Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?

Judy A Tjoe, Philippe Gascard, Jianxin Zhao, Gary F Neitzel, Maharaj Singh, Brittany Last, James Marx, Thea Tlsty, Sanjay Kansra

Advocate Health - Midwest

Research output: Other contribution

Original language	American English
Status	Published - Nov 20 2015

Keywords

breast cancer
atypia
invasive carcinoma
biomarker expression

Disciplines

Biological Phenomena, Cell Phenomena, and Immunity
Neoplasms
Oncology
Surgery

Access to Document

Does the Expression of Ki-67 p16 and COX-2 at Initial DiagnosisFinal published version, 216 KBLicense: Unspecified

Cite this

@misc{824e7bf3149f4379a673ea0363b5e1e1,

title = "Does the Expression of Ki-67, p16 and COX-2 at Initial Diagnosis of Breast Atypia or Usual Ductal Hyperplasia Predict a Second Clinically Significant Event?",

keywords = "breast cancer, atypia, invasive carcinoma, biomarker expression",

author = "Tjoe, {Judy A} and Philippe Gascard and Jianxin Zhao and Neitzel, {Gary F} and Maharaj Singh and Brittany Last and James Marx and Thea Tlsty and Sanjay Kansra",

year = "2015",

month = nov,

day = "20",